UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
November 14, 2001
-----------------
(Date of Report)
Claimsnet.com inc.
------------------
(Exact name of registrant as specified in its charter)
Delaware 001-14665 75-2649230
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
12801 N. Central Expressway, Suite 1515, Dallas, Texas 75243
------------------------------------------------------------
(Address of principal executive offices)
(972) 458-1701
--------------
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Item 7. Financial Statements and Exhibits
(a) Exhibits
99.1 Script of November 13, 2001 Analyst and Investor Conference
Call.
99.2 Press Release dated November 13, 2001 related to Registrant's
third quarter 2001 results.
Item 9. Regulation FD Disclosure.
On November 13, 2001, the Registrant held a conference call for
analysts and investors regarding its third quarter 2001 operating results, a
copy of the script for which is attached hereto as Exhibit 99.1, and the press
release issued in connection with such results is attached hereto as Exhibit
99.2.
During the question and answer session at the close of the conference
call for analysts and investors regarding their third quarter 2001 operating
results, the management of the Registrant disclosed the following:
o Management estimated that the dip in transaction activity in September
2001 was approximately 7% to 10% and further indicated that October
transaction activity rebounded to show an increase of approximately
20%.
o Management reported that the Registrant has successfully converted all
of its patient statement business to a new vendor without the loss of
any accounts, has set internal goals which have not been made public,
and is in the process of establishing a joint marketing plan with the
new vendor to increase patient statement business.
o Management stated that they believe the revenue model for eligibility
transactions will be similar to the more established model for
electronic claims. Specifically, management estimated that some payers
will pay a transaction fee in the range of $.25 to $.35 and other
payers will not be willing to pay a transaction fee, in which case the
requesting provider will be expected to pay a transaction fee in the
range of $.25 to $.35. Revenues from payer sources are likely to be
shared between the Registrant and the company providing access to the
payer's eligibility data, if applicable.
o Management reported that it has realigned the responsibilities of
certain existing employees to dedicate more resources to sales and
marketing efforts and has contracted with an independent representative
to pursue business opportunities with the large-payer market.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: November 14, 2001
CLAIMSNET.COM INC.
By: /s/ Paul W. Miller
--------------------------------
Name: Paul W. Miller
Title: Chief Financial Officer